Virtual Event | July 14, 2022

Asia Pacific: The Growing Clinical Trial Hot Spot

Source: Clinical Leader

The Asian-Pacific (APAC) region is one of the fastest growing areas for clinical trials. There are many benefits to conducting trials in the region, including low cost, ease of regulatory compliance, a growing patient population, and the presence of top clinical institutions. The APAC CRO market was valued at $7.6 billion in 2021 and is forecasted to reach $12 billion by 2025. 

Still, there are challenges that drug developers must be aware of if planning to conduct studies in the APAC region. Those challenges include the lingering impact of COVID, geopolitics, and regulatory idiosyncrasies.

Check out this On-Demand webinar from Clinical Leader Live featuring experts covering all aspects of trial conduct in this growing clinical hot spot. 

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)